The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You

Summary

Background

It is well known that the transfer of a patient from hospital to the general practitioner is related with mistakes in the medication of the patient. A report from 2006 measure the number of drug related admissions in Denmark to be 69.000 to 162.000 per year. To reduce these mistakes, more and better communication between the health professionals are suggested. Furthermore medication reviews made by pharmacist seems to reduce the number of drug related readmissions and other drug related issues, which can lead to an economic cost reduction.

Objective

The aim of this study is to investigate the impact of medication review and better communication between the health professionals after discharge of a patient from hospital to the general practitioner. The effect is measured as reducing the number of readmissions and number of visits at the emergency department 30 days and six month after inclusion of the patient.

Method

This study was estimated to include 1500 participants. The patients were randomized to one of three groups; usual care, basic intervention or extended intervention. The usual care received the normal care following the Danish standard procedure. The basic intervention had a medication review by a clinical pharmacist during admission.

The extended interventions group was similar to the basic intervention group plus follow-up with the patient, the general practitioner and if relevant the nursing home and pharmacy one week and six month after discharge by interview with the clinical pharmacist.

Conditions

• Cross-Sectional Study

Interventions

OTHER

basic intervention

medication review

OTHER

extended intervention

medication review, medication interview before discharge and follow-up

Sponsors & Collaborators

• The Hospitals Pharmacies' and Amgros' Research Development Foundation

  collaborator UNKNOWN

• University of Southern Denmark

  collaborator OTHER

• Two public Regional foundations

  collaborator UNKNOWN

• The Actavis Foundation

  collaborator UNKNOWN

• Lene V. Ravn-Nielsen

  lead OTHER

Principal Investigators

• Lene V. Ravn-Nielsen, M.Sc.Pharm · Hospital Pharmacy of Funen

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Model

FACTORIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2013-09-01

Primary Completion

2015-04-24

Completion

2015-10-24